Design and synthesis of bioreductive prodrugs of class I histone deacetylase inhibitors and their biological evaluation in virally transfected acute myeloid leukemia cells

被引:1
|
作者
Abdelsalam, Mohamed [1 ,2 ]
Zmyslia, Mariia [3 ]
Schmidtkunz, Karin [4 ]
Vecchio, Anita [1 ]
Hilscher, Sebastian [5 ]
Ibrahim, Hany S. [1 ,6 ]
Schutkowski, Mike [5 ]
Jung, Manfred [4 ,7 ]
Jessen-Trefzer, Claudia [3 ,8 ]
Sippl, Wolfgang [1 ,9 ]
机构
[1] Martin Luther Univ Halle Wittenberg, Dept Med Chem, Halle, Germany
[2] Alexandria Univ, Fac Pharm, Dept Pharmaceut Chem, Alexandria, Egypt
[3] Univ Freiburg, Inst Organ Chem, Freiburg, Germany
[4] Univ Freiburg, Inst Pharmaceut Sci, Freiburg, Germany
[5] Martin Luther Univ Halle Wittenberg, Inst Biochem, Dept Enzymol, Halle, Germany
[6] Egyptian Russian Univ, Fac Pharm, Dept Pharmaceut Chem, Cairo, Egypt
[7] Univ Freiburg, CIBSS Ctr Integrat Biol Signalling Studies, Freiburg, Germany
[8] Univ Freiburg, Inst Organ Chem, D-79104 Freiburg, Germany
[9] Martin Luther Univ Halle Wittenberg, Inst Pharm, Dept Med Chem, D-06120 Halle, Germany
关键词
epigenetics; HDACs; hypoxia; nitroreductases; prodrugs; NITROREDUCTASE; HYPOXIA; ENZYME; GDEPT;
D O I
10.1002/ardp.202300536
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Although histone deacetylase (HDAC) inhibitors show promise in treating various types of hematologic malignancies, they have some limitations, including poor pharmacokinetics and off-target side effects. Prodrug design has shown promise as an approach to improve pharmacokinetic properties and to improve target tissue specificity. In this work, several bioreductive prodrugs for class I HDACs were designed based on known selective HDAC inhibitors. The zinc-binding group of the HDAC inhibitors was masked with various nitroarylmethyl residues to make them substrates of nitroreductase (NTR). The developed prodrugs showed weak HDAC inhibitory activity compared to their parent inhibitors. The prodrugs were tested against wild-type and NTR-transfected THP1 cells. Cellular assays showed that both 2-nitroimidazole-based prodrugs 5 and 6 were best activated by the NTR and exhibited potent activity against NTR-THP1 cells. Compound 6 showed the highest cellular activity (GI50 = 77 nM) and exhibited moderate selectivity. Moreover, activation of prodrug 6 by NTR was confirmed by liquid chromatography-mass spectrometry analysis, which showed the release of the parent inhibitor after incubation with Escherichia coli NTR. Thus, compound 6 can be considered a novel prodrug selective for class I HDACs, which could be used as a good starting point for increasing selectivity and for further optimization. A new series of prodrugs for class I histone deacetylases (HDACs) was designed and synthesized by masking the zinc-binding group of reported HDAC1-3 inhibitors with different nitroaromatic moieties. Among these prodrugs, compound 6 showed the most potent inhibitory activity against nitroreductase (NTR)-transfected leukemic cells. Liquid chromatography-mass spectrometry analysis confirmed the activation of compound 6 and showed the release of its parent inhibitor after incubation with NTR.image
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Design, synthesis, and biological evaluation of N-hydroxycinnamamide/salicylic acid hybrids as histone deacetylase inhibitors
    Tao You
    Ke Chen
    Fei-Hai Wang
    Pi-Hong Li
    Li-Yi Li
    Zhi-Hao Wu
    Kong-Hai Ni
    Zhi-Qiang Zheng
    Chinese Chemical Letters, 2014, 25 (03) : 474 - 478
  • [42] Histone deacetylase inhibitors reduce differentiating osteoblast-mediated protection of acute myeloid leukemia cells from cytarabine
    Sterner, Rosalie M.
    Kremer, Kimberly N.
    Al-Kali, Aref
    Patnaik, Mrinal M.
    Gangat, Naseema
    Litzow, Mark R.
    Kaufmann, Scott H.
    Westendorf, Jennifer J.
    van Wijnen, Andre J.
    Hedin, Karen E.
    ONCOTARGET, 2017, 8 (55) : 94569 - 94579
  • [43] Design, Synthesis, and Biological Activity of Hydroxamic Tertiary Amines as Histone Deacetylase Inhibitors
    Terracciano, Stefania
    Chini, Maria Giovanna
    Riccio, Raffaele
    Bruno, Ines
    Bifulco, Giuseppe
    CHEMMEDCHEM, 2012, 7 (04) : 694 - 702
  • [44] Synthesis and Biological Evaluation of JAHAs: Ferrocene-Based Histone Deacetylase Inhibitors
    Spencer, John
    Amin, Jahangir
    Wang, Minghua
    Packham, Graham
    Alwi, Sharifah S. Syed
    Tizzard, Graham J.
    Coles, Simon J.
    Paranal, Ronald M.
    Bradner, James E.
    Heightman, Tom D.
    ACS MEDICINAL CHEMISTRY LETTERS, 2011, 2 (05): : 358 - 362
  • [45] Effect of histone deacetylase inhibitor valproic acid on progenitor cells of acute myeloid leukemia
    Bug, Gesine
    Schwarz, Kerstin
    Schoch, Claudia
    Kampfmann, Manuela
    Henschler, Reinhard
    Hoelzer, Dieter
    Ottmann, Oliver G.
    Ruthardt, Martin
    HAEMATOLOGICA, 2007, 92 (04) : 542 - 545
  • [46] Synthesis and biological evaluation of aminobenzamides containing purine moiety as class I histone deacetylases inhibitors
    Mao, Ping-Ting
    He, Wei-Bao
    Mai, Xi
    Feng, Li-Hua
    Li, Na
    Liao, Yi-Jing
    Zhu, Cai-Sheng
    Li, Jian
    Chen, Ting
    Liu, Shu-Hao
    Zhang, Qi-Ming
    He, Ling
    BIOORGANIC & MEDICINAL CHEMISTRY, 2022, 56
  • [47] Design, Synthesis, and Biological Evaluation of Orally Bioavailable CHK1 Inhibitors Active against Acute Myeloid Leukemia
    Jin, Tingting
    Wang, Peipei
    Long, Xiubing
    Jiang, Kailong
    Song, Pinrao
    Wu, Wenbiao
    Xu, Gaoya
    Zhou, Yubo
    Li, Jia
    Liu, Tao
    CHEMMEDCHEM, 2021, 16 (09) : 1477 - 1487
  • [48] Design, synthesis and biological evaluation of quinoline derivatives as HDAC class I inhibitors
    Chen, Chen
    Hou, Xuben
    Wang, Guohua
    Pan, Wenyan
    Yang, Xinying
    Zhang, Yingkai
    Fang, Hao
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 133 : 11 - 23
  • [49] SYNERGISITC INTERACTION OF BORTEZOMIB AND HISTONE DEACETYLASE INHIBITORS IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA CELLS
    Bastian, L.
    Einsiedel, H. Graf
    Prada, J.
    Fichter, I.
    Henze, G.
    Shalapour, S.
    Seeger, K.
    ANNALS OF HEMATOLOGY, 2011, 90 : S23 - S23
  • [50] Design, Synthesis, Biological Evaluation, and Structural Characterization of Potent Histone Deacetylase Inhibitors Based on Cyclic α/β-Tetrapeptide Architectures
    Montero, Ana
    Beierle, John M.
    Olsen, Christian A.
    Ghadiri, M. Reza
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2009, 131 (08) : 3033 - 3041